JATT Acquisition (JATT) Competitors $2.21 +0.01 (+0.45%) As of 09/8/2025 Add Compare Share Share Competitors Stock AnalysisChartCompetitorsSEC FilingsTrendsBuy This Stock JATT vs. FBRX, HURA, CHRS, BHST, ACOG, IKT, ZURA, CABA, CRDF, and PLXShould you be buying JATT Acquisition stock or one of its competitors? The main competitors of JATT Acquisition include Forte Biosciences (FBRX), TuHURA Biosciences (HURA), Coherus Oncology (CHRS), BioHarvest Sciences (BHST), Alpha Cognition (ACOG), Inhibikase Therapeutics (IKT), Zura Bio (ZURA), Cabaletta Bio (CABA), Cardiff Oncology (CRDF), and Protalix BioTherapeutics (PLX). These companies are all part of the "pharmaceutical products" industry. JATT Acquisition vs. Its Competitors Forte Biosciences TuHURA Biosciences Coherus Oncology BioHarvest Sciences Alpha Cognition Inhibikase Therapeutics Zura Bio Cabaletta Bio Cardiff Oncology Protalix BioTherapeutics JATT Acquisition (NYSE:JATT) and Forte Biosciences (NASDAQ:FBRX) are both small-cap medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their media sentiment, dividends, profitability, risk, analyst recommendations, valuation, earnings and institutional ownership. Which has better earnings and valuation, JATT or FBRX? CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioJATT AcquisitionN/AN/A$6.85MN/AN/AForte BiosciencesN/AN/A-$35.48M-$16.29-0.68 Do analysts prefer JATT or FBRX? Forte Biosciences has a consensus target price of $68.00, suggesting a potential upside of 514.83%. Given Forte Biosciences' stronger consensus rating and higher probable upside, analysts plainly believe Forte Biosciences is more favorable than JATT Acquisition.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score JATT Acquisition 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00Forte Biosciences 0 Sell rating(s) 0 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 3.00 Do insiders & institutionals hold more shares of JATT or FBRX? 48.0% of JATT Acquisition shares are held by institutional investors. Comparatively, 77.6% of Forte Biosciences shares are held by institutional investors. 20.0% of JATT Acquisition shares are held by company insiders. Comparatively, 5.9% of Forte Biosciences shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term. Does the media refer more to JATT or FBRX? In the previous week, Forte Biosciences had 2 more articles in the media than JATT Acquisition. MarketBeat recorded 2 mentions for Forte Biosciences and 0 mentions for JATT Acquisition. Forte Biosciences' average media sentiment score of 0.67 beat JATT Acquisition's score of 0.00 indicating that Forte Biosciences is being referred to more favorably in the news media. Company Overall Sentiment JATT Acquisition Neutral Forte Biosciences Positive Is JATT or FBRX more profitable? JATT Acquisition's return on equity of -49.58% beat Forte Biosciences' return on equity.Company Net Margins Return on Equity Return on Assets JATT AcquisitionN/A -49.58% 2.84% Forte Biosciences N/A -85.38%-72.34% SummaryForte Biosciences beats JATT Acquisition on 6 of the 10 factors compared between the two stocks. Get JATT Acquisition News Delivered to You Automatically Sign up to receive the latest news and ratings for JATT and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding JATT and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart JATT vs. The Competition Export to ExcelMetricJATT AcquisitionBiological Products IndustryMedical SectorNYSE ExchangeMarket Cap$38.12M$287.63M$5.83B$21.25BDividend YieldN/AN/A6.70%3.49%P/E RatioN/AN/A75.7629.44Price / SalesN/A435.36454.7448.75Price / Cash27.0822.4425.7018.06Price / Book-4.1711.2111.494.58Net Income$6.85M-$115.81M$3.28B$999.91M7 Day Performance8.33%3.48%1.25%0.83%1 Month Performance55.63%10.27%11.23%5.23%1 Year Performance-38.95%-14.13%59.55%16.63% JATT Acquisition Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)JATTJATT AcquisitionN/A$2.21+0.5%N/A-39.2%$38.12MN/A0.003High Trading VolumeFBRXForte Biosciences3.3929 of 5 stars$11.07+0.2%$68.00+514.3%+46.3%$137.39MN/A-0.685News CoveragePositive NewsShort Interest ↓HURATuHURA Biosciences1.8389 of 5 stars$2.60+0.4%$12.67+387.2%N/A$135.13MN/A0.00N/ACHRSCoherus Oncology4.0391 of 5 stars$1.26+5.9%$4.51+258.1%+10.5%$134.82M$266.96M0.81330BHSTBioHarvest SciencesN/A$7.65-1.9%$13.67+78.6%N/A$134.36M$25.19M-10.93N/AGap UpACOGAlpha Cognition2.246 of 5 stars$8.16+0.1%$20.00+145.1%N/A$134.13MN/A-5.10N/APositive NewsIKTInhibikase Therapeutics0.008 of 5 stars$1.73-1.7%N/AN/A$134.13M$260K0.006ZURAZura Bio3.3278 of 5 stars$2.03+0.5%$14.00+589.7%-39.0%$132.64MN/A-2.903Positive NewsCABACabaletta Bio2.5746 of 5 stars$1.57+8.3%$14.43+819.0%-60.6%$132.62MN/A-0.5850CRDFCardiff Oncology3.1398 of 5 stars$1.96+0.5%$10.10+415.3%+5.7%$129.73M$545K-2.2520News CoveragePLXProtalix BioTherapeutics3.1324 of 5 stars$1.60-2.4%$15.00+837.5%+58.0%$127.57M$61.95M-12.31200Positive News Related Companies and Tools Related Companies FBRX Alternatives HURA Alternatives CHRS Alternatives BHST Alternatives ACOG Alternatives IKT Alternatives ZURA Alternatives CABA Alternatives CRDF Alternatives PLX Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NYSE:JATT) was last updated on 9/9/2025 by MarketBeat.com Staff From Our PartnersWhy Trump’s “Smart Dollar” could rewrite the rulesMUST SEE: Donald Trump's Radical Overhaul of the U.S. Dollar Congress just approved President Trump's lates...Stansberry Research | SponsoredBuffett, Gates and Bezos Dumping StocksThe world's wealthiest individuals are making huge moves with their money. Warren Buffett just liquidated b...Banyan Hill Publishing | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | Sponsored“Sell Nvidia before earnings”Eric Fry just went live with one of his most controversial calls yet: “Sell Nvidia.” While Wall Street has bee...InvestorPlace | Sponsored2013 Bitcoin miner reveals his trading system (free)While everyone else is gambling on meme coins or chasing the next "100x moonshot," our members are systematica...Crypto Swap Profits | SponsoredForget Tesla — This Tiny AI Stock Is Musk’s Real PlayWhile Wall Street focused on Tesla’s earnings, Elon Musk was quietly building a supercomputer so powerful it c...Behind the Markets | SponsoredWhat's the Best Way to Lower RMD Taxes?Turning 73 triggers a key IRS rule: you must begin taking required minimum distributions (RMDs) from certain r...SmartAsset | SponsoredTurn $1K into $50K with This DeFi GemBitcoin grabs headlines, but smart money likes this token My research team has identified the token positio...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding JATT Acquisition Corp Please log in to your account or sign up in order to add this asset to your watchlist. Share JATT Acquisition With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
